PharVision Advisers’s Chewy CHWY Stock Holding History

PharVision Advisers’s Portfolio CHWY Stock Details CHWY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,184	Closed	-$210K	–	727
2025 Q3	$210K	Sell	5,184 -252	-5%	-$9.72K	0.12%	480
2025 Q2	$232K	Buy	+5,436	New	+$217K	0.33%	162

Other funds holding CHWY

BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PharVision Advisers's CHWY Position: Q4 2025 in Review

PharVision Advisers sold out of Chewy (CHWY) in Q4 2025, closing a stake of 5,184 shares — an estimated $210K sold.

PharVision Advisers first reported a position in CHWY in Q2 2025 and held it in 2 quarters. The position peaked at $232K in Q2 2025. 582 funds tracked by Wall St. Rank hold CHWY as of Q4 2025.

PharVision Advisers reported no remaining Chewy position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 5,184 Chewy shares in Q4 2025, an estimated $210K.
PharVision Advisers first reported a position in Chewy in Q2 2025 and held it in 2 quarters.
PharVision Advisers's Chewy position peaked at $232K in Q2 2025.
582 funds tracked by Wall St. Rank held Chewy as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.